Skip to main content

Overview of Current Imaging Modalities in Prostate Cancer

Videos — October 20, 2021
Neal Shore, MD, FACS
Carolina Urologic Research Center
Myrtle Beach, SC
Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY® (piflufolastat F 18).

Related Items